CPIG
RNTX

Chicago Partners Investment Group’s Rein Therapeutics RNTX Stock Holding History

Chicago Partners Investment Group’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Hold
41,048
– – ﹤0.01% 1526
2026
Q1 		$77.2K Buy
41,048
+10,000
+32% +$12.4K ﹤0.01% 1404
2025
Q4 		$42.5K Hold
31,048
– – ﹤0.01% 1283
2025
Q3 		$41K Sell
31,048
-10,194
-25% -$12.9K ﹤0.01% 1202
2025
Q2 		$63.9K Buy
41,242
+5,330
+15% +$9.6K ﹤0.01% 1076
2025
Q1 		$58.5K Buy
+35,912
New +$75.4K ﹤0.01% 913

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Chicago Partners Investment Group's RNTX Position: Q2 2026 in Review

Chicago Partners Investment Group held its Rein Therapeutics (RNTX) position steady in Q2 2026 at 41,048 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Chicago Partners Investment Group first reported a position in RNTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $77.2K in Q1 2026. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Chicago Partners Investment Group held 41,048 shares of Rein Therapeutics worth $32.8K as of Q2 2026.
  • Chicago Partners Investment Group left its Rein Therapeutics share count unchanged in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1526 holding.
  • Chicago Partners Investment Group first reported a position in Rein Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Chicago Partners Investment Group's Rein Therapeutics position peaked at $77.2K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.